Purpose of the development: Technology is used in the treatment of potent and highly toxic drugs cancer and tuberculosis.

Recommended application field: medicine

Advantages over analogues: Used in this way the drug acts targeted: in the place where it is needed, and does not affect other organs of man, by providing far fewer side effects than usual. The technology allows a few times to reduce the required dose of the drug, and, consequently, the toxic effect on the body as a whole.

The development stage readiness: Pre-production model is made

Description of the development:
()
Based on nanotechnology, a special carrier for drugs, which is under the influence of a magnetic field delivers medication directly to the affected organ. Developed a unique low-cost technology of a new drug carrier - sorbent carbon nanotubes, perfectly compatible with the body - tsefesorba. A unique feature of the sorbent is that it is transported by injection directly into the affected area, concentrating in it one hundred percent of medicines and completely eliminating the harmful effects on the human body.

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua